Baterna, Rowelyn G.
HRN: 08-99-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2023
CEFTRIAXONE 1G (VIAL)
03/01/2023
03/07/2023
IV
2g
OD
Sepsis Sec To Gingival Abscess
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes